Verrica Pharmaceuticals I...

AI Score

0

Unlock

0.66
0.02 (3.09%)
At close: Jan 17, 2025, 3:59 PM
0.68
2.63%
After-hours Jan 17, 2025, 05:32 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -4.95 -3.39 -6.37 -6.32 -14.15 -5.79 -78.28 -182.47
PS Ratio 64.77 10.40 20.64 n/a n/a n/a n/a n/a
PB Ratio 16.79 2.35 7.60 8.72 6.09 1.34 41.23 -131.03
P/FCF Ratio -8.52 -4.96 -8.7 -9.08 -14.08 -6.41 -76.16 -216.67
P/OCF Ratio -8.6 -5.04 -8.98 -9.52 -14.43 -6.69 -76.16 -216.67
OCF/S Ratio -7.53 -2.06 -2.3 n/a n/a n/a n/a n/a
Debt / Equity Ratio 2.30 0.04 1.33 1.07 0.00 n/a n/a -0.01
Quick Ratio 4.49 11.45 1.61 1.66 19.39 36.26 14.75 1.30
Current Ratio 4.55 11.31 1.61 1.66 19.39 36.26 14.75 1.30
Asset Turnover 0.06 0.20 0.15 n/a n/a n/a n/a n/a
Interest Coverage -16.6 -9.8 -7.2 -13.25 n/a n/a -2.23K n/a
Return on Equity (ROE) -3.39 -0.69 -1.19 -1.38 -0.43 -0.23 -0.53 0.72
Return on Assets (ROA) -0.82 -0.62 -0.49 -0.61 -0.41 -0.22 -0.49 -3.52
Return on Capital (ROIC) -1.02 -0.52 -0.91 -1.16 -0.46 -0.24 -0.53 -15.3
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 85.44% 91.97% 96.07% n/a n/a n/a n/a n/a
Net Profit Margin -1.31K% -306.44% -324.19% n/a n/a n/a n/a n/a
Pretax Profit Margin -1.31K% -271.11% -292.33% n/a n/a n/a n/a n/a
Operating Profit Margin -1.28K% -235.78% -257.57% n/a n/a n/a n/a n/a
FCF Margin -759.93% -209.83% -237.21% n/a n/a n/a n/a n/a
EBITDA Margin -1.21K% -239.12% -252.61% n/a n/a n/a n/a n/a